Body Protection Compound-157 (pentadecapeptide)
A synthetic pentadecapeptide derived from a sequence identified in gastric juice, studied in cytoprotection and tissue-repair research models.
BPC-157 is a synthetic peptide composed of 15 amino acids. Its sequence is derived from a portion of a protein identified in gastric juice, and it is frequently referenced in preclinical cytoprotection research.
Published studies on BPC-157 are largely preclinical (cell and animal models). It is a research compound and has not been established as a safe or effective treatment for any condition in humans.
It is a laboratory identifier for the specific 15-amino-acid sequence studied, not a measure of strength or grade.
No. Existing research is largely preclinical. NorthPeak makes no treatment claims and presents this as an informational research entry.
Research disclaimer. All information on NorthPeak Peptides is provided for educational and informational purposes only. It is not medical advice and is not intended to diagnose, treat, cure, or prevent any disease. Materials referenced are described for research context and are not offered for human consumption. Always consult a qualified, licensed healthcare professional regarding your health.
Ala-Glu-Asp-Gly tetrapeptide
A synthetic tetrapeptide studied in cellular-aging and telomere research models.
View Research ProfileTriple incretin receptor agonist (investigational)
An investigational synthetic peptide studied as a triple agonist of the GIP, GLP-1, and glucagon receptors in metabolic research.
View Research ProfileSynthetic peptide related to Thymosin β-4
A synthetic peptide associated with the actin-binding region of Thymosin β-4, studied in cell-migration and tissue-repair research models.
View Research Profile